Marco Dal Molin, MD

Marco Dal Molin, M.D., is a surgical oncologist that specializes in hepatobiliary, pancreatic and gastrointestinal surgical oncology at the Johns Hopkins Hospital. 

Dr. Dal Molin earned his medical degree at the University of Verona School of Medicine in Italy, followed by a general surgery residency at the University of Verona/Pancreas Institute. He completed a second general surgery residency at the University of Maryland in Baltimore, and a fellowship in Complex General Surgical Oncology at Johns Hopkins.

Dr. Dal Molin received extensive postdoctoral research training at Johns Hopkins, including an NIH-funded T32 research fellowship prior to joining the surgical faculty.

He specializes in the management of patients with pancreatic cancer, pancreatic cysts, as well as cancers of the liver, biliary tree and gastrointestinal tract. He is trained in traditional open and minimally invasive techniques to treating these cancers, using both laparoscopic and robotic approaches.

Dr. Dal Molin’s research focuses on the development of liquid biopsies to improve the earlier detection and management of pancreatic cancer and pancreatic cysts. Another area of focus is the development of novel immunotherapies to treat pancreatic and hepatobiliary cancers.